Lapatinib - Novartis
At a glance
- Drug Originator GlaxoSmithKline
- Drug Licenced by Eddingpharm; Nippon Kayaku
- Drug Class Antineoplastics; Chlorobenzenes; Fluorobenzenes; Furans; Phenyl ethers; Quinazolines; Small molecules; Sulfones
- Mechanism of Action Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists
- USA Patent Applicants NOVARTIS
- USA Patents 7
- NDAs 1
- International Patents 28
- Patent Applications 3,327

Disclaimer